Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1-2 trial
多替拉韦分散片在 HIV-1 感染婴幼儿中的药代动力学、安全性、耐受性和抗病毒活性（IMPAACT P1093）：一项开放标签的 1/2 期试验结果
期刊:Lancet HIV
影响因子:13
doi:10.1016/S2352-3018(22)00044-3
Ruel, Theodore D; Acosta, Edward P; Liu, Jessica P; Gray, Kathryn P; George, Kathleen; Montañez, Nicole; Popson, Stephanie; Buchanan, Ann M; Bartlett, Mattie; Dayton, Dale; Anthony, Patricia; Brothers, Cynthia; Vavro, Cynthia; Singh, Rajendra; Koech, Lucy; Vhembo, Tichaona; Mmbaga, Blandina T; Pinto, Jorge A; Dobbels, Els F M; Archary, Moherndran; Chokephaibulkit, Kulkanya; Ounchanum, Pradthana; Deville, Jaime G; Hazra, Rohan; Townley, Ellen; Wiznia, Andrew
